+
データを開く
-
基本情報
登録情報 | データベース: PDB / ID: 1gua | ||||||
---|---|---|---|---|---|---|---|
タイトル | HUMAN RAP1A, RESIDUES 1-167, DOUBLE MUTANT (E30D,K31E) COMPLEXED WITH GPPNHP AND THE RAS-BINDING-DOMAIN OF HUMAN C-RAF1, RESIDUES 51-131 | ||||||
![]() |
| ||||||
![]() | COMPLEX (GTP-BINDING/ATP-BINDING) / ONCOGENE PROTEIN/KINASE/EFFECTOR PROTEIN GTP-BINDING-PROTEIN / COMPLEX (GTP-BINDING-ATP-BINDING) / COMPLEX (GTP-BINDING-ATP-BINDING) complex | ||||||
機能・相同性 | ![]() positive regulation of Fc receptor mediated stimulatory signaling pathway / Rap protein signal transduction / death-inducing signaling complex assembly / regulation of cell junction assembly / response to antineoplastic agent / intermediate filament cytoskeleton organization / nerve growth factor signaling pathway / negative regulation of collagen biosynthetic process / positive regulation of vasculogenesis / guanyl-nucleotide exchange factor complex ...positive regulation of Fc receptor mediated stimulatory signaling pathway / Rap protein signal transduction / death-inducing signaling complex assembly / regulation of cell junction assembly / response to antineoplastic agent / intermediate filament cytoskeleton organization / nerve growth factor signaling pathway / negative regulation of collagen biosynthetic process / positive regulation of vasculogenesis / guanyl-nucleotide exchange factor complex / negative regulation of synaptic vesicle exocytosis / regulation of Rho protein signal transduction / type B pancreatic cell proliferation / ARMS-mediated activation / SHOC2 M1731 mutant abolishes MRAS complex function / Gain-of-function MRAS complexes activate RAF signaling / response to carbohydrate / Rap1 signalling / establishment of endothelial barrier / MET activates RAP1 and RAC1 / insulin secretion involved in cellular response to glucose stimulus / anchoring junction / Negative feedback regulation of MAPK pathway / IFNG signaling activates MAPKs / GP1b-IX-V activation signalling / Frs2-mediated activation / p130Cas linkage to MAPK signaling for integrins / ERBB2-ERBB3 signaling pathway / neurotrophin TRK receptor signaling pathway / regulation of neurotransmitter receptor localization to postsynaptic specialization membrane / pseudopodium / face development / GRB2:SOS provides linkage to MAPK signaling for Integrins / regulation of cell differentiation / positive regulation of protein kinase activity / thyroid gland development / synaptic vesicle exocytosis / extrinsic apoptotic signaling pathway via death domain receptors / somatic stem cell population maintenance / positive regulation of GTPase activity / positive regulation of peptidyl-serine phosphorylation / MAP kinase kinase kinase activity / type II interferon-mediated signaling pathway / negative regulation of protein-containing complex assembly / Schwann cell development / negative regulation of extrinsic apoptotic signaling pathway via death domain receptors / specific granule membrane / phagocytic vesicle / sperm midpiece / response to muscle stretch / Integrin signaling / myelination / liver regeneration / CD209 (DC-SIGN) signaling / insulin-like growth factor receptor signaling pathway / positive regulation of phagocytosis / guanyl-nucleotide exchange factor activity / adenylate cyclase activator activity / thymus development / cellular response to cAMP / small monomeric GTPase / protein localization to plasma membrane / positive regulation of D-glucose import / Stimuli-sensing channels / wound healing / RAF activation / Signaling by high-kinase activity BRAF mutants / MAP2K and MAPK activation / positive regulation of neuron projection development / cellular response to nerve growth factor stimulus / small GTPase binding / Negative regulation of MAPK pathway / cellular response to xenobiotic stimulus / Signaling by RAF1 mutants / Signaling by moderate kinase activity BRAF mutants / Paradoxical activation of RAF signaling by kinase inactive BRAF / Signaling downstream of RAS mutants / GDP binding / Glucagon-like Peptide-1 (GLP1) regulates insulin secretion / Signaling by BRAF and RAF1 fusions / cell junction / late endosome / insulin receptor signaling pathway / nervous system development / MAPK cascade / presynapse / G protein activity / regulation of apoptotic process / mitochondrial outer membrane / early endosome / neuron projection / endosome membrane / positive regulation of ERK1 and ERK2 cascade / protein phosphorylation / non-specific serine/threonine protein kinase / protein kinase activity / positive regulation of MAPK cascade / negative regulation of cell population proliferation / protein serine kinase activity / GTPase activity 類似検索 - 分子機能 | ||||||
生物種 | ![]() | ||||||
手法 | ![]() | ||||||
![]() | Nassar, N. / Wittinghofer, A. | ||||||
![]() | ![]() タイトル: Ras/Rap effector specificity determined by charge reversal. 著者: Nassar, N. / Horn, G. / Herrmann, C. / Block, C. / Janknecht, R. / Wittinghofer, A. #1: ![]() タイトル: Quantitative Structure-Activity Analysis Correlating Ras/Raf Interaction in Vitro to Raf Activation in Vivo 著者: Block, C. / Janknecht, R. / Herrmann, C. / Nassar, N. / Wittinghofer, A. #2: ![]() タイトル: Quantitative Analysis of the Complex between P21Ras and the Ras-Binding Domain of the Human Raf-1 Protein Kinase 著者: Herrmann, C. / Martin, G.A. / Wittinghofer, A. #3: ![]() タイトル: The 2.2 A Crystal Structure of the Ras-Binding Domain of the Serine/Threonine Kinase C-Raf1 in Complex with RAP1A and a GTP Analogue 著者: Nassar, N. / Horn, G. / Herrmann, C. / Scherer, A. / Mccormick, F. / Wittinghofer, A. | ||||||
履歴 |
|
-
構造の表示
構造ビューア | 分子: ![]() ![]() |
---|
-
ダウンロードとリンク
-
ダウンロード
PDBx/mmCIF形式 | ![]() | 65.9 KB | 表示 | ![]() |
---|---|---|---|---|
PDB形式 | ![]() | 46.9 KB | 表示 | ![]() |
PDBx/mmJSON形式 | ![]() | ツリー表示 | ![]() | |
その他 | ![]() |
-検証レポート
文書・要旨 | ![]() | 462.4 KB | 表示 | ![]() |
---|---|---|---|---|
文書・詳細版 | ![]() | 464.3 KB | 表示 | |
XML形式データ | ![]() | 7.1 KB | 表示 | |
CIF形式データ | ![]() | 10.4 KB | 表示 | |
アーカイブディレクトリ | ![]() ![]() | HTTPS FTP |
-関連構造データ
-
リンク
-
集合体
登録構造単位 | ![]()
| ||||||||
---|---|---|---|---|---|---|---|---|---|
1 |
| ||||||||
単位格子 |
|
-
要素
-タンパク質 , 2種, 2分子 AB
#1: タンパク質 | 分子量: 19041.549 Da / 分子数: 1 / 断片: RESIDUES 1-167 / 変異: E30D, K31E, DEL(168-186) / 由来タイプ: 組換発現 / 詳細: COMPLEXED TO 5'-GUANOSYL-IMIDO-TRIPHOSPHATE / 由来: (組換発現) ![]() ![]() ![]() |
---|---|
#2: タンパク質 | 分子量: 9203.765 Da / 分子数: 1 / 断片: RESIDUES 51-131 / 由来タイプ: 組換発現 / 詳細: HUMAN RAP1A AND C-RAF1 / 由来: (組換発現) ![]() 解説: PURIFIED AS A GST-FUSION PROTEIN WITH THROMBIN CLEAVAGE SITE 遺伝子: HUMAN C-RAF1 GENE RESIDUES 51 / プラスミド: PGEX-RAFRBD / 生物種 (発現宿主): Escherichia coli 遺伝子 (発現宿主): HUMAN C-RAF1 GENE, RESIDUES 51-131 発現宿主: ![]() ![]() 参照: UniProt: P04049, 転移酵素; リンを含む基を移すもの; キナーゼ(アルコールにつなげるもの) |
-非ポリマー , 4種, 92分子 






#3: 化合物 | ChemComp-MG / |
---|---|
#4: 化合物 | ChemComp-GNP / |
#5: 化合物 | ChemComp-CA / |
#6: 水 | ChemComp-HOH / |
-実験情報
-実験
実験 | 手法: ![]() |
---|
-
試料調製
結晶 | マシュー密度: 2.84 Å3/Da / 溶媒含有率: 51 % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
結晶 | *PLUS 溶媒含有率: 50 % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
結晶化 | *PLUS 温度: 19 ℃ / pH: 7.6 / 手法: 蒸気拡散法, ハンギングドロップ法 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
溶液の組成 | *PLUS
|
-データ収集
放射光源 | 波長: 1.5418 |
---|---|
検出器 | タイプ: SIEMENS HI-STAR / 検出器: AREA DETECTOR |
放射 | 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray |
放射波長 | 波長: 1.5418 Å / 相対比: 1 |
反射 | Num. obs: 21975 / % possible obs: 98 % / Observed criterion σ(I): 0 / 冗長度: 5.1 % / Rmerge(I) obs: 0.049 |
反射 | *PLUS 最高解像度: 2 Å / Num. obs: 26720 / Rmerge(I) obs: 0.041 |
-
解析
ソフトウェア |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
精密化 | 解像度: 2→8 Å / σ(F): 0 詳細: THE ELECTRON DENSITY FOR THE SIDE CHAINS OF RESIDUES 104 - 107 FROM RBD (CHAIN B) IS WEAK.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
原子変位パラメータ | Biso mean: 16.9 Å2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Refine analyze | Luzzati coordinate error obs: 0.25 Å / Luzzati sigma a obs: 0.21 Å | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
精密化ステップ | サイクル: LAST / 解像度: 2→8 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
拘束条件 |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ソフトウェア | *PLUS 名称: ![]() | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
精密化 | *PLUS Rfactor obs: 0.22 / Rfactor Rwork: 0.22 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
溶媒の処理 | *PLUS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
原子変位パラメータ | *PLUS |